Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocata Therapeutics Inc (NASDAQ:OCAT)

4.16
Delayed Data
As of 12:41pm ET
 -0.195 / -4.48%
Today’s Change
3.55
Today|||52-Week Range
12.73
-31.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues39.5K39.5K39.5K39.5K
 
 
 
 
 
Cost of Goods Sold129.0015.6K15.6K15.6K
 
 
 
 
 
Depreciation And Amortization31.0K33.4K63.7K65.1K
 
 
 
 
 
 
Operating ExpensesGross Income8.4K-9.5K-39.8K-41.3K
 
 
 
 
 
General Expenses5.8M4.9M6.8M7.0M
 
 
 
 
 
Research And Development2.5M2.7M2.9M3.4M
 
 
 
 
 
Total Operating Expenses5.8M4.9M6.9M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-4.9M-6.8M-7.0M
 
 
 
 
 
Extraordinary Credit0.001.4M25.0K6.0K
 
 
 
 
Extraordinary Charge-2.7M-11.9M0.000.00
 
 
 
Interest Expense On Debt297.0K132.5K0.000.00
 
 
 
Other Expenses0.000.00-10.9K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.7M-15.5M-6.8M-7.0M
 
 
 
 
 
Net Income-8.7M-15.5M-6.8M-7.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.0M29.6M34.6M34.9M
 
 
 
 
 
Shares To Calculate EPS Diluted28.0M29.6M34.6M34.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$1.00-$0.20-$0.20
 
 
 
 
EPS Diluted-$0.31-$1.00-$0.20-$0.20